Comparison of the prevalence of islet autoantibodies according to age and disease duration in patients with type 1 diabetes mellitus

PurposeThis study investigated the prevalence of islet autoantibodies in children and adults with T1DM according to their age and the duration of disease.MethodsWe measured the levels of islet autoantibodies, including antiglutamic acid decarboxylase antibody (anti-GAD Ab), and combined these with a...

Full description

Bibliographic Details
Main Authors: Young Hwa Kong, Min Sun Kim, Dae-Yeol Lee
Format: Article
Language:English
Published: Korean Society of Pediatric Endocrinology 2013-06-01
Series:Annals of Pediatric Endocrinology & Metabolism
Subjects:
Online Access:http://e-apem.org/upload/pdf/apem-18-65.pdf
_version_ 1818309323406704640
author Young Hwa Kong
Min Sun Kim
Dae-Yeol Lee
author_facet Young Hwa Kong
Min Sun Kim
Dae-Yeol Lee
author_sort Young Hwa Kong
collection DOAJ
description PurposeThis study investigated the prevalence of islet autoantibodies in children and adults with T1DM according to their age and the duration of disease.MethodsWe measured the levels of islet autoantibodies, including antiglutamic acid decarboxylase antibody (anti-GAD Ab), and combined these with anthropometric measurements and laboratory tests of 137 patients newly diagnosed with T1DM during the last 20 years. The subjects were subdivided into four groups according to their age at the onset of the disease. We then compared the prevalence of islet autoantibodies in the different age groups with the duration of disease.ResultsAmong the 137 patients, 68.9% tested positive for islet autoantibodies (71.4% within 1 year; 67.7% after 1 year of the disease onset). Within 1 year of the onset of the disease, 66.3% of the patients were positive for the anti-GAD Ab, and 35.6% were positive for IAAs. The prevalence of islet autoantibodies was significantly higher in the prepubertal groups than in the postpubertal groups (80.0% vs. 58.3%). The rate of positive islet autoantibodies changed with the duration of disease, and it differed according to the type of autoantibody and the age of the patient.ConclusionThe rates of positive islet autoantibodies were significantly higher in younger than in older patients at the time of the diagnosis of the disease. The positive rates were significantly changed 1 year after the onset of the disease in the preschool and the children groups. So these findings suggest that we need to diagnose type 1B diabetes distinguished T2DM in aldolescent group, carefully.
first_indexed 2024-12-13T07:28:20Z
format Article
id doaj.art-669d40b7a6734826aded6f51b381e685
institution Directory Open Access Journal
issn 2287-1012
2287-1292
language English
last_indexed 2024-12-13T07:28:20Z
publishDate 2013-06-01
publisher Korean Society of Pediatric Endocrinology
record_format Article
series Annals of Pediatric Endocrinology & Metabolism
spelling doaj.art-669d40b7a6734826aded6f51b381e6852022-12-21T23:55:16ZengKorean Society of Pediatric EndocrinologyAnnals of Pediatric Endocrinology & Metabolism2287-10122287-12922013-06-01182657010.6065/apem.2013.18.2.65526Comparison of the prevalence of islet autoantibodies according to age and disease duration in patients with type 1 diabetes mellitusYoung Hwa Kong0Min Sun Kim1Dae-Yeol Lee2Department of Pediatrics, Chonbuk National University Medical School, Jeonju, Korea.Department of Pediatrics, Chonbuk National University Medical School, Jeonju, Korea.Department of Pediatrics, Chonbuk National University Medical School, Jeonju, Korea.PurposeThis study investigated the prevalence of islet autoantibodies in children and adults with T1DM according to their age and the duration of disease.MethodsWe measured the levels of islet autoantibodies, including antiglutamic acid decarboxylase antibody (anti-GAD Ab), and combined these with anthropometric measurements and laboratory tests of 137 patients newly diagnosed with T1DM during the last 20 years. The subjects were subdivided into four groups according to their age at the onset of the disease. We then compared the prevalence of islet autoantibodies in the different age groups with the duration of disease.ResultsAmong the 137 patients, 68.9% tested positive for islet autoantibodies (71.4% within 1 year; 67.7% after 1 year of the disease onset). Within 1 year of the onset of the disease, 66.3% of the patients were positive for the anti-GAD Ab, and 35.6% were positive for IAAs. The prevalence of islet autoantibodies was significantly higher in the prepubertal groups than in the postpubertal groups (80.0% vs. 58.3%). The rate of positive islet autoantibodies changed with the duration of disease, and it differed according to the type of autoantibody and the age of the patient.ConclusionThe rates of positive islet autoantibodies were significantly higher in younger than in older patients at the time of the diagnosis of the disease. The positive rates were significantly changed 1 year after the onset of the disease in the preschool and the children groups. So these findings suggest that we need to diagnose type 1B diabetes distinguished T2DM in aldolescent group, carefully.http://e-apem.org/upload/pdf/apem-18-65.pdfIslet autoantibodyType 1 diabetes mellitusGlutamic acid decarboxylaseInsulin autoantibody
spellingShingle Young Hwa Kong
Min Sun Kim
Dae-Yeol Lee
Comparison of the prevalence of islet autoantibodies according to age and disease duration in patients with type 1 diabetes mellitus
Annals of Pediatric Endocrinology & Metabolism
Islet autoantibody
Type 1 diabetes mellitus
Glutamic acid decarboxylase
Insulin autoantibody
title Comparison of the prevalence of islet autoantibodies according to age and disease duration in patients with type 1 diabetes mellitus
title_full Comparison of the prevalence of islet autoantibodies according to age and disease duration in patients with type 1 diabetes mellitus
title_fullStr Comparison of the prevalence of islet autoantibodies according to age and disease duration in patients with type 1 diabetes mellitus
title_full_unstemmed Comparison of the prevalence of islet autoantibodies according to age and disease duration in patients with type 1 diabetes mellitus
title_short Comparison of the prevalence of islet autoantibodies according to age and disease duration in patients with type 1 diabetes mellitus
title_sort comparison of the prevalence of islet autoantibodies according to age and disease duration in patients with type 1 diabetes mellitus
topic Islet autoantibody
Type 1 diabetes mellitus
Glutamic acid decarboxylase
Insulin autoantibody
url http://e-apem.org/upload/pdf/apem-18-65.pdf
work_keys_str_mv AT younghwakong comparisonoftheprevalenceofisletautoantibodiesaccordingtoageanddiseasedurationinpatientswithtype1diabetesmellitus
AT minsunkim comparisonoftheprevalenceofisletautoantibodiesaccordingtoageanddiseasedurationinpatientswithtype1diabetesmellitus
AT daeyeollee comparisonoftheprevalenceofisletautoantibodiesaccordingtoageanddiseasedurationinpatientswithtype1diabetesmellitus